Cargando…
Listening to the Patient Voice Adds Value to Cancer Clinical Trials
Randomized clinical trials are critical for evaluating the safety and efficacy of interventions in oncology and informing regulatory decisions, practice guidelines, and health policy. Patient-reported outcomes (PROs) are increasingly used in randomized trials to reflect the impact of receiving cance...
Autores principales: | Brundage, Michael D, Crossnohere, Norah L, O’Donnell, Jennifer, Cruz Rivera, Samantha, Wilson, Roger, Wu, Albert W, Moher, David, Kyte, Derek, Reeve, Bryce B, Gilbert, Alexandra, Chen, Ronald C, Calvert, Melanie J, Snyder, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552306/ https://www.ncbi.nlm.nih.gov/pubmed/35900186 http://dx.doi.org/10.1093/jnci/djac128 |
Ejemplares similares
-
The PROTEUS-Trials Consortium: Optimizing the use of patient-reported outcomes in clinical trials
por: Snyder, Claire, et al.
Publicado: (2022) -
The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
por: Cruz Rivera, Samantha, et al.
Publicado: (2020) -
“The patient is speaking”: discovering the patient voice in ophthalmology
por: Dean, Samera, et al.
Publicado: (2017) -
It's ok to listen to the gray voice
por: Garbarek, Jan, 1947-
Publicado: (1985) -
Assessing the impact of healthcare research: A systematic review of methodological frameworks
por: Cruz Rivera, Samantha, et al.
Publicado: (2017)